RGEN Q2 2021 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q2 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$163M+86.3% YoY

Gross Profit

$101M62.0% margin

Operating Income

$48M29.6% margin

Net Income

$36M22.2% margin

EPS (Diluted)

$0.64

QoQ Revenue Growth

+14.1%

Cash Flow

Operating Cash Flow

$38M

Free Cash Flow

$20M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$413M

Stockholders' Equity

$1.6B

Cash & Equivalents

$734M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$163M	$87M	+86.3%
Gross Profit	$101M	$51M	+99.5%
Operating Income	$48M	$20M	+146.9%
Net Income	$36M	$16M	+128.4%

Revenue Segments

Product

$163M100%

Royalty

$40,0000%